Menu

• Ask a Health Expert about TUMOUR INVASION
• Post Your Side Effect related to TUMOUR INVASION
• TUMOUR INVASION and FDA Warnings
• TUMOUR INVASION in Patients Wiki
• Report TUMOUR INVASION in Drug Side Effect Survey

TUMOUR INVASION side effect

What is TUMOUR INVASION ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Fentanyl Side Effects Report #5778026-5
Consumer or non-health professional from UNITED STATES reported FENTANYL TRANSDERMAL SYSTEM problem on June 09, 2008. Female patient, weighting 170.0 lb, was diagnosed with pain management and was treated with FENTANYL TRANSDERMAL SYSTEM. After drug was administered, patient experienced the following problems/side effects: malaise, tumour invasion, . FENTANYL TRANSDERMAL SYSTEM dosage: unknown. During the same period patient was treated with WARFARIN. Patient recovered.

Humira Side Effects Report #5749429-X
HUMIRA problem was reported by a Physician from UNITED STATES on May 21, 2008. Female patient, weighting 166.0 lb, was diagnosed with rheumatoid arthritis and was treated with HUMIRA. After drug was administered, patient experienced the following problems/side effects: malignant melanoma, tumour invasion, . HUMIRA dosage: 40MG SC Q2W. Patient recovered.

Rebif Side Effects Report #5482002-X
Consumer or non-health professional from UNITED STATES reported REBIF problem on Sept 26, 2007. Female patient, 62 years of age, weighting 131.0 lb, was diagnosed with multiple sclerosis and was treated with REBIF. After drug was administered, patient experienced the following problems/side effects: colon cancer, metastases to bladder, tumour invasion, urinary tract infection, . REBIF dosage: unknown. During the same period patient was treated with NOVANTRONE. Patient was hospitalized. Patient recovered.

Tysabri Side Effects Report #5727324-X
TYSABRI problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 24, 2008. Female patient, 60 years of age, was diagnosed with multiple sclerosis and was treated with TYSABRI. After drug was administered, patient experienced the following problems/side effects: malignant melanoma, mass, tumour invasion, . TYSABRI dosage: 300 MG;QM;IV. Patient recovered.


Dactinomycin Side Effects Report #5354788-6
Health Professional from JAPAN reported DACTINOMYCIN problem on May 30, 2007. Female patient, 32 years of age, was diagnosed with choriocarcinoma and was treated with DACTINOMYCIN. After drug was administered, patient experienced the following problems/side effects: choriocarcinoma, condition aggravated, tumour invasion, tumour necrosis, uterine haemorrhage, . DACTINOMYCIN dosage: unknown. During the same period patient was treated with METHOTREXATE, ETOPOSIDE. Patient was hospitalized. Patient recovered.